Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Notice: Prescription Drug List (PDL): Hyoscine butylbromide August 26, 2016 Our file number: 16-109536-761 The purpose of this Notice of Amendment is to notify that Health Canada will switch injectable Hyoscine butylbromide to prescription status from ethical status for human use…
Notice: Prescription Drug List (PDL): Multiple additions August 26, 2016 Our file number: 16-109523-230 The purpose of this Notice of Amendment is to notify the additions of Asunaprevir, Bilastine, Daratumumab, Elotuzumab, Idarucizumab, Ixekizumab, Olaparib, Osimertinib,…
Notice: Prescription Drug List (PDL): Multiple additions August 9, 2016 Our file number: 16-108811-710 The purpose of this Notice of Amendment is to notify the additions of Alirocumab, Blinatumomab, Brivaracetam, Carfilzomib, Cobimetinib, Elbasvir, Finafloxacin, Grazoprevir,…
Notice: Prescription Drug List (PDL): Naloxone Qualifier Change February 2, 2017 Our file number: 17-101266-74 The purpose of this Notice of Amendment is to notify that Health Canada has revised the Qualifier for Naloxone on the Prescription Drug List. The listing now reads:…
Notice: Prescription Drug List (PDL): Naloxone March 22, 2016 Our file number: 16-103373-445 The purpose of this Notice of Amendment is to notify that as a result of consultation Health Canada has revised the listing for naloxone on the Prescription Drug List (PDL). Health Canada…
Notice - Prescription Drug List (PDL): Ibuprofen February 5, 2016 Our file number: 16-101201-525 The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Ibuprofen to nonprescription status for human…
Notice: Prescription Drug List (PDL): Ibuprofen August 18, 2016 Our file number: 16-109277-453 The purpose of this Notice of Amendment is to notify that Health Canada will switch certain uses of Ibuprofen to nonprescription status for human use by modifying the Human Prescription…
Notice: Prescription Drug List (PDL): Hyoscine butylbromide February 12, 2016 Our file number: 16-101454-524 The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch injectable Hyoscine butylbromide to prescription…
Notice: Prescription Drug List (PDL): Fluticasone propionate February 26, 2016 Our file number: 16-101933-448 The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the…
Notice: Prescription Drug List (PDL): Fluticasone propionate August 26, 2016 Our file number: 16-109530-552 The purpose of this Notice of Amendment is to notify that Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt…
Early release: coverage and features are still expanding.
